News

EUFEPS

Comac Medical Scientific Team will join EUFEPS, the Open Forum Discussion on the ICH Draft Guideline on the Bioequivalence of Immediate Release Dosage Forms on Monday, May 15 in Frankfurt, Germany.

There are some modifications in bioequivalence requirements, relevant for European companies which should initiate comprehensive scientific discussion.

This event will give an opportunity to discuss the new regulations with European representatives of the ICH-Guideline’s drafting group and present our views and suggestions, based on our own experience, during the discussion.

Share:
Comac Medical is proud to announce the appointment of Peter Windisch as its new Chief Operations Officer (COO).
For small to mid-sized biotech companies, navigating the complexities of clinical trials can be challenging. With limited resources,...
Sofia, November 15th 2024 – Comac Medical is proud to announce the launch of new sustainability initiatives aimed...